Table 6.
Predictors of Symptom Severity at 20 Weeks
| Variable | β | df | Type III SS | F | p |
|---|---|---|---|---|---|
| Group | 46.67 | 1 | 1,607.89 | 6.06 | 0.02 |
| Control | - | - | - | - | - |
| Intervention | - | - | - | - | - |
| Symptom severity at baseline | 0.35 | 1 | 1,843.16 | 6.95 | 0.01 |
| Gender | 1.49 | 1 | 22.54 | 0.08 | 0.77 |
| Female | - | - | - | - | - |
| Male | - | - | - | - | - |
| Age | 0.15 | 1 | 342.31 | 1.29 | 0.26 |
| Depressive symptoms at baseline | 0.64 | 1 | 1,188.53 | 4.48 | 0.04 |
| Site of cancer | - | 3 | 547.58 | 0.69 | 0.56 |
| Breast | -3.46 | - | - | - | - |
| Other | -7.04 | - | - | - | - |
| Lung | - | - | - | - | - |
| Age times group interaction | -0.70 | 1 | 1,323.14 | 4.99 | 0.03 |
N = 84
Note. All possible interactions were tested. Only signifi cant interactions were included in the fi nal model.